Catharine C. Bulik
- Pharmacology top 1%
- Molecular Medicine top 0.5%
- Epidemiology top 10%
- Applied Microbiology and Biotechnology top 0.5%
- Clinical Biochemistry top 5%
- Co-authors
- David P. NicolauJoseph L. KutiJared L. CrandonSujata M. BhavnaniPaul G. AmbroseAlan ForrestChristina SutherlandÓlanrewaju O. Okusanya
- Topics
- Antibiotics Pharmacokinetics and Efficacy (22 papers)Antibiotic Resistance in Bacteria (17 papers)Pneumonia and Respiratory Infections (11 papers)
- Journals
- Clinical Cancer ResearchJournal of Clinical MicrobiologyAntimicrobial Agents and Chemotherapy
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Catharine C. Bulik
26 papers receiving 997 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 739
- Molecular Medicine 736
- Epidemiology 415
- Applied Microbiology and Biotechnology 255
- Clinical Biochemistry 140
Countries citing papers authored by Catharine C. Bulik
This map shows the geographic impact of Catharine C. Bulik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catharine C. Bulik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catharine C. Bulik more than expected).
Fields of papers citing papers by Catharine C. Bulik
This network shows the impact of papers produced by Catharine C. Bulik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catharine C. Bulik. The network helps show where Catharine C. Bulik may publish in the future.
Co-authorship network of co-authors of Catharine C. Bulik
This figure shows the co-authorship network connecting the top 25 collaborators of Catharine C. Bulik. A scholar is included among the top collaborators of Catharine C. Bulik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catharine C. Bulik. Catharine C. Bulik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 12 | |
| 3 | 7 | |
| 4 | 11 | |
| 5 | 1 | |
| 6 | 28 | |
| 7 | 46 | |
| 8 | 20 | |
| 9 | 62 | |
| 10 | 12 | |
| 11 | 50 | |
| 12 | 47 | |
| 13 | 65 | |
| 14 | 43 | |
| 15 | 13 | |
| 16 | 26 | |
| 17 | 29 | |
| 18 | 96 | |
| 19 | 37 | |
| 20 | 49 |
About Catharine C. Bulik
Catharine C. Bulik is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 26 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Antibiotic Resistance in Bacteria (17 papers) and Pneumonia and Respiratory Infections (11 papers). The work is most often cited by research in Molecular Medicine (736 citations), Applied Microbiology and Biotechnology (255 citations) and Pharmacology (739 citations). Catharine C. Bulik has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include David P. Nicolau, Joseph L. Kuti, Jared L. Crandon, Sujata M. Bhavnani, Paul G. Ambrose, Alan Forrest, Christina Sutherland, Ólanrewaju O. Okusanya, Henry Christensen and Brian VanScoy. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.